166 related articles for article (PubMed ID: 26766733)
21. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
22. Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme.
White B; Power E; Ciurej M; Lo SH; Nash K; Ormiston-Smith N
Biomed Res Int; 2015; 2015():928251. PubMed ID: 26525423
[TBL] [Abstract][Full Text] [Related]
23. Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study.
Denis B; Gendre I; Perrin P
J Med Screen; 2015 Jun; 22(2):76-82. PubMed ID: 25576338
[TBL] [Abstract][Full Text] [Related]
24. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
26. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test.
Plumb AA; Ghanouni A; Rainbow S; Djedovic N; Marshall S; Stein J; Taylor SA; Halligan S; Lyratzopoulos G; von Wagner C
J Med Screen; 2017 Mar; 24(1):12-19. PubMed ID: 27216771
[TBL] [Abstract][Full Text] [Related]
27. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
28. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach.
Fraser CG; Mathew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Gut; 2007 Oct; 56(10):1415-8. PubMed ID: 17309886
[TBL] [Abstract][Full Text] [Related]
30. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?
Hoeck S; van de Veerdonk W; De Brabander I
Eur J Cancer Prev; 2020 Mar; 29(2):119-126. PubMed ID: 31724969
[TBL] [Abstract][Full Text] [Related]
31. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
[TBL] [Abstract][Full Text] [Related]
32. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
Trials; 2015 Jul; 16():296. PubMed ID: 26156248
[TBL] [Abstract][Full Text] [Related]
33. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
34. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round.
Blom J; Kilpeläinen S; Hultcrantz R; Törnberg S
J Med Screen; 2014 Sep; 21(3):144-50. PubMed ID: 25070434
[TBL] [Abstract][Full Text] [Related]
35. Experience with a wipe guaiac-based faecal occult blood test as an alternative test in a bowel screening programme.
Fraser CG; McDonald PJ; Colford L; Irvine A; Kenicer M; Morton C; Birrell J; Steele RJ
J Med Screen; 2010; 17(4):211-3. PubMed ID: 21258132
[TBL] [Abstract][Full Text] [Related]
36. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
37. Guaiac faecal occult blood screening in individuals younger than 50 years of age.
Zalts R; Moadi Z; Avizohar O; Leiba R; Half E; Karban A
Eur J Cancer Prev; 2017 May; 26(3):189-194. PubMed ID: 27167151
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
[TBL] [Abstract][Full Text] [Related]
39. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
[TBL] [Abstract][Full Text] [Related]
40. The contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer.
Barnett KN; Weller D; Smith S; Steele RJ; Vedsted P; Orbell S; Moss SM; Melia JW; Patnick J; Campbell C
Health Expect; 2018 Aug; 21(4):764-773. PubMed ID: 29457677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
